(2S)-N-[(1S)-1-(2-Cyclopropylethylcarbamoyl)-4-guanidino-butyl]-1-[(2S)-1-[(2S)-1-[4-[3-(3,4-dichlorophenyl)anilino]-4-oxo-butanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxamide

ID: ALA5197024

Chembl Id: CHEMBL5197024

PubChem CID: 168286363

Max Phase: Preclinical

Molecular Formula: C42H55Cl2N9O6

Molecular Weight: 852.86

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CCC(=O)Nc1cccc(-c2ccc(Cl)c(Cl)c2)c1)C(=O)NCCC1CC1

Standard InChI:  InChI=1S/C42H55Cl2N9O6/c43-30-15-14-28(25-31(30)44)27-6-1-7-29(24-27)49-36(54)16-17-37(55)51-21-4-10-34(51)40(58)53-23-5-11-35(53)41(59)52-22-3-9-33(52)39(57)50-32(8-2-19-48-42(45)46)38(56)47-20-18-26-12-13-26/h1,6-7,14-15,24-26,32-35H,2-5,8-13,16-23H2,(H,47,56)(H,49,54)(H,50,57)(H4,45,46,48)/t32-,33-,34-,35-/m0/s1

Standard InChI Key:  JXOUXWWKTWFKCQ-BBACVFHCSA-N

Alternative Forms

  1. Parent:

    ALA5197024

    ---

Associated Targets(Human)

NCF1 Tbio Neutrophil cytosol factor 1 (245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 852.86Molecular Weight (Monoisotopic): 851.3652AlogP: 4.02#Rotatable Bonds: 17
Polar Surface Area: 210.13Molecular Species: BASEHBA: 7HBD: 6
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.45CX Basic pKa: 11.85CX LogP: 1.89CX LogD: -0.20
Aromatic Rings: 2Heavy Atoms: 59QED Weighted: 0.08Np Likeness Score: -0.82

References

1. Garsi JB, Komjáti B, Cullia G, Fejes I, Sipos M, Sipos Z, Fördős E, Markacz P, Balázs B, Lancelot N, Berger S, Raimbaud E, Brown D, Vuillard LM, Haberkorn L, Cukier C, Szlávik Z, Hanessian S..  (2022)  Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics.,  13  (6.0): [PMID:35707140] [10.1021/acsmedchemlett.2c00094]

Source